Researchers at Oregon State University have developed a new way to selectively insert compounds into cancer cells – a system that will help surgeons identify malignant tissues and then, in combination with phototherapy, kill any remaining cancer cells after a tumor is removed.
It’s about as simple as, “If it glows, cut it out.” And if a few malignant cells remain, they’ll soon die.
The findings, published in the journal Nanoscale, have shown remarkable success in laboratory animals. The concept should allow more accurate surgical removal of solid tumors at the same time it eradicates any remaining cancer cells. In laboratory tests, it completely prevented cancer recurrence after phototherapy.
Technology such as this, scientists said, may have a promising future in the identification and surgical removal of malignant tumors, as well as using near-infrared light therapies that can kill remaining cancer cells, both by mild heating of them and generating reactive oxygen species that can also kill them.
“This is kind of a double attack that could significantly improve the success of cancer surgeries,” said Oleh Taratula, an assistant professor in the OSU College of Pharmacy.
“With this approach, cancerous cells and tumors will literally glow and fluoresce when exposed to near-infrared light, giving the surgeon a precise guide about what to remove,” Taratula said. “That same light will activate compounds in the cancer cells that will kill any malignant cells that remain. It’s an exciting new approach to help surgery succeed.”
The Latest on: Phototherapy
via Google News
The Latest on: Phototherapy
- Neonatal Phototherapy Devices Market : Industry Analysis and Opportunity Assessment | By Kenneth Researchon February 24, 2021 at 5:22 am
Such factors are anticipated to drive the growth of the NEONATAL PHOTOTHERAPY DEVICES MARKET during the forecast period. Click Here to Download Sample Report >> Due to COVID-19 pandemic, the Neonatal ...
- Amgen submits sNDA to US FDA for Otezla to treat adults with mild-to-moderate plaque psoriasison February 24, 2021 at 2:30 am
Amgen submits sNDA to US FDA for Otezla to treat adults with mild-to-moderate plaque psoriasis: Thousand Oaks, California Wednesday, February 24, 2021, 16:00 Hrs [IST] Amgen annou ...
- Amgen Submits Supplemental New Drug Application for Otezla® (apremilast) for Adults with Mild-To-Moderate Plaque Psoriasison February 23, 2021 at 7:20 am
Amgen (NASDAQ:AMGN) today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for Otezla® (apremilast) for the treatment of adults ...
- Amgen looks to expand access to Otezla in the USon February 23, 2021 at 1:45 am
Amgen has submitted a supplemental new drug application (sNDA) seeking expanded approval for Otezla in adults with mild-to-moderate plaque psoriasis who are candidates for phototherapy or systemic ...
- Amgen Submits SNDA For Otezla For Adults With Mild-To-Moderate Plaque Psoriasison February 22, 2021 at 6:22 am
Amgen (AMGN) said that it has submitted a supplemental New Drug Application or sNDA to the U.S. Food and Drug Administration for Otezla or apremilast for the treatment of adults with mild-to-moderate ...
- Unichem Labs gets USFDA nod for plaque psoriasis drugon February 19, 2021 at 12:33 am
Apremilast tablets are used to treat adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy Drug firm Unichem Laboratories on Friday said ...
- Unichem Laboratories gets USFDA nod for plaque psoriasis treatment drugon February 18, 2021 at 10:25 pm
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
- Unichem Laboratories gets USFDA nod for plaque psoriasis treatment drugon February 18, 2021 at 10:05 pm
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. The company has received ...
- Infant Phototherapy Lamp Market Size 2021–Industry Analysis, Size, Share, Trends, Market Demand, Growth, Opportunities and Forecast 2026on February 18, 2021 at 8:51 pm
The MarketWatch News Department was not involved in the creation of this content. Feb 19, 2021 (The Expresswire) -- In 2021 ,Infant Phototherapy Lamp Market “Size, Trend, Analysis, growth, Trend, ...
- About Your Phototherapy Procedureon February 17, 2021 at 4:00 pm
This information explains what phototherapy is and what to expect before, during, and after your procedure. The goal of phototherapy is to reduce the growth of your skin cells and to treat underlying ...
via Bing News